Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease

NCT04429867 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

700

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo

Sponsor

WellStar Health System